Revenue: As of FY2025 Q3, the actual value is USD 2.959 M.EPS: As of FY2025 Q3, the actual value is USD -0.03.EBIT: As of FY2025 Q3, the actual value is USD -318 K.<h3>Segment Revenue</h3><ul><li>Medical Market: Revenue increased to $1,084 thousand for the three months ended September 30, 2025, from $574 thousand for the same period in 2024, representing a growth of 88.9%.</li><li>Industrial Market: Revenue decreased to $888 thousand for the three months ended September 30, 2025, from $1,232 thousand for the same period in 2024, representing a decline of 27.9%.</li><li>Automotive Market: Revenue decreased to $28 thousand for the three months ended September 30, 2025, from $132 thousand for the same period in 2024, representing a decline of 78.8%.</li><li>Standard Products: Revenue increased to $959 thousand for the three months ended September 30, 2025, from $733 thousand for the same period in 2024, representing a growth of 30.8%.</li></ul><h3>Operational Metrics</h3><ul><li>Gross Profit: Increased to $1,238 thousand for the three months ended September 30, 2025, from $1,105 thousand for the same period in 2024, representing a growth of 12.0%.</li><li>Gross Margin: Slightly increased to 41.8% for the three months ended September 30, 2025, from 41.4% for the same period in 2024.</li><li>Engineering, Research and Development Expenses: Decreased to $354 thousand for the three months ended September 30, 2025, from $486 thousand for the same period in 2024, representing a decline of 27.2%.</li><li>Selling, General and Administrative Expenses: Increased to $1,197 thousand for the three months ended September 30, 2025, from $1,095 thousand for the same period in 2024, representing a growth of 9.3%.</li><li>Net Loss: Decreased to $336 thousand for the three months ended September 30, 2025, from $523 thousand for the same period in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Provided by Operating Activities: $244 thousand for the nine months ended September 30, 2025, compared to net cash used in operating activities of $144 thousand for the same period in 2024.</li><li>Net Cash Used in Investing Activities: $37 thousand for the nine months ended September 30, 2025, compared to $107 thousand for the same period in 2024.</li><li>Net Cash Used in Financing Activities: $193 thousand for the nine months ended September 30, 2025, compared to $300 thousand for the same period in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to continue investing in the expansion of its technology platforms through internal development and potential strategic relationships with companies and technology institutes to support growth initiatives.</li><li>Non-Core Business: The company converted all of its Series A Convertible Preferred Stock into common stock on October 15, 2025, which will eliminate the payment of $400,000 per annum in dividends previously payable to holders of preferred stock.</li></ul>

Interlink Electronics | 10-Q: FY2025 Q3 Revenue: USD 2.959 M